Login to Your Account

Pharma: Other News To Note

Friday, November 9, 2012

• Mylan Inc., of Pittsburgh, and Famy Care Ltd., of Mumbai, India, agreed to a settlement with Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, of New Brunswick, N.J., resolving patent litigation related to norgestimate/ethinyl estradiol tablets 0. 180 mg/0.025 mg, 0.215 mg/0.025 mg and 0.250 mg/0.025 mg, the generic version of Janssen's Ortho Tri-Cyclen Lo tablets, indicated for the prevention of pregnancy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription